Dehghan Manshadi Seyed Ali, Shafiee Nahid, Piri Seyed Mohammad, Naghavi Erfan, Moradi Maryam
Department of Infectious Disease and Tropical Medicine/ Iranian Research Center for HIV/AIDS (IRCHA) Tehran University of Medical Sciences Tehran Iran.
Department of Infectious Disease and Tropical Medicine Tehran University of Medical Sciences Tehran Iran.
Clin Case Rep. 2024 Feb 9;12(2):e8507. doi: 10.1002/ccr3.8507. eCollection 2024 Feb.
Tuberculosis (TB) is a rare but known reason for hypercalcemia usually in those with underlying conditions such as renal failure, diabetes, or severe anemia. It is essential to consider TB in those with refractory or resistant hypercalcemia.
Hypercalcemia or a calcium level above 10.5 mg/dL can be a manifestation of TB that only became symptomatic in a small percentage of the patients. Patients with underlying diseases such as renal failure are more prone to poor prognosis. It is essential to use anti-TB drugs besides hypercalcemia standard treatment to maintain a normal calcium level in TB-related hypercalcemia. In thisstudy, we have presented a young adult with disseminated TB and persistent hypercalcemia who responded finally to anti-TB drugs.
结核病（TB）是高钙血症的一种罕见但已知的病因，通常发生在患有诸如肾衰竭、糖尿病或严重贫血等基础疾病的患者中。对于难治性或耐药性高钙血症患者，必须考虑结核病。
高钙血症或血钙水平高于10.5mg/dL可能是结核病的一种表现，只有一小部分患者出现症状。患有诸如肾衰竭等基础疾病的患者预后往往较差。对于与结核病相关的高钙血症，除了高钙血症标准治疗外，使用抗结核药物以维持正常血钙水平至关重要。在本研究中，我们报告了一名患有播散性结核病和持续性高钙血症的年轻成年人，其最终对抗结核药物产生了反应。
